You are here

Quick Reference – Changes to the Georgia PDMP Law

July 26, 2017
  1. By January 1, 2018, every prescriber with a DEA number is required to enroll to become a user of the PDMP. Currently, registration may be done through the website. If a DEA number is obtained after that date, then enrollment must take place within 30 days of receipt.
  2. Effective July 1, 2018, PDMP information must be checked the first time a prescription for a controlled substance is issued and thereafter every 90 days. Controlled substances include hydrocodone, codeine, oxycodone and benzodiazepines. A more complete list may be found here.
  3. A prescriber may delegate authority to check the PDMP to two members of their staff per shift or rotation. For unlicensed or unregistered staff (i.e., an office manager or medical assistant), the staff member must submit to an annual registration process that will be administered by the Georgia Board of Pharmacy.  The delegates may retrieve and review PDMP information for the purpose of providing care to an individual patient or informing the prescriber of a patient’s potential use, misuse, abuse or underutilization of prescribed medication. 
  4. Inquiries to the PDMP must be noted in the medical record along with the date and time and the name of the individual doing the search.  Information obtained from the PDMP may be included in the patient’s medical record.
  5. Prescribers who issue prescriptions for opioids must provide the patient with written and/or verbal information on the addictive risks of using opioids and options available for the safe disposal of unused drugs.
  6. Exemptions from the requirement to check the database are as follows:
  • Prescriptions for no more than a three-day supply of a covered substance and no more than 26 pills 
  • The patient is in a hospital or health care facility, including a nursing home, an intermediate care home, a personal care home, or a hospice program that provides patient care and the prescriptions are administered and used by a patient on the premises of the facility 
  • The patient has had outpatient surgery at a hospital or ambulatory surgical center and the prescription is for no more than a 10-day supply and no more than 40 pills 
  • The patient is terminally ill or under the supervised care of an outpatient hospice program 
  • The patient is receiving treatment for cancer

For additional information please review our recent article or review House Bill 249.

Disclaimer

The information provided in this resource does not constitute legal, medical or any other professional advice, nor does it establish a standard of care. This article has been written as an aid to you in your practice. The ultimate decision on how to use the information provided within this article rests solely with you, the PolicyOwner.

Footnotes